Novo Nordisk A/S (NVO)
NYSE: NVO · Real-Time Price · USD
69.72
-4.05 (-5.49%)
At close: Jun 23, 2025, 4:00 PM
70.00
+0.28 (0.40%)
After-hours: Jun 23, 2025, 7:59 PM EDT
Novo Nordisk Employees
As of December 31, 2024, Novo Nordisk had 77,349 total employees, including 76,302 full-time and 1,047 part-time employees. The number of employees increased by 13,030 or 20.26% compared to the previous year.
Employees
77,349
Change (1Y)
13,030
Growth (1Y)
20.26%
Revenue / Employee
$567,845
Profits / Employee
$195,965
Market Cap
309.67B
Employees Chart
Employees History
Date | Employees | Change | Growth |
---|---|---|---|
Dec 31, 2024 | 77,349 | 13,030 | 20.26% |
Dec 31, 2023 | 64,319 | 9,134 | 16.55% |
Dec 31, 2022 | 55,185 | 6,707 | 13.84% |
Dec 31, 2021 | 48,478 | 3,155 | 6.96% |
Dec 31, 2020 | 45,323 | 2,065 | 4.77% |
Dec 31, 2019 | Pro | Pro | Pro |
Dec 31, 2018 | Pro | Pro | Pro |
Dec 31, 2017 | Pro | Pro | Pro |
Dec 31, 2016 | Pro | Pro | Pro |
Dec 31, 2015 | Pro | Pro | Pro |
Related Stocks
Company Name | Employees |
---|---|
UnitedHealth Group | 400,000 |
Johnson & Johnson | 138,100 |
Thermo Fisher Scientific | 125,000 |
Abbott Laboratories | 114,000 |
AstraZeneca | 94,300 |
Novartis AG | 75,883 |
Merck & Co. | 75,000 |
AbbVie | 55,000 |
NVO News
- 35 minutes ago - Novo Nordisk launches blockuster weight-loss drug Wegovy in India - Reuters
- 12 hours ago - EU drug regulator allows Novo Nordisk to include heart condition in Ozempic label - Reuters
- 12 hours ago - Novo Nordisk A/S: Ozempic® receives EU recommendation in peripheral arterial disease, cementing the broad benefits of semaglutide for people with type 2 diabetes and comorbidities - GlobeNewsWire
- 14 hours ago - Novo Nordisk Ends Partnership with Hims & Hers - WSJ
- 17 hours ago - Hims & Hers' stock plunges. Here's why Wegovy parent ended its partnership with the company. - Market Watch
- 18 hours ago - Novo Nordisk's Weight Loss Injection CagriSema Data Sparks Investor Concern - Benzinga
- 18 hours ago - Hims & Hers Stock Plunges as Novo Nordisk Abruptly Ends Partnership - Barrons
- 19 hours ago - Novo Nordisk ends deal with Hims & Hers over sales of Wegovy copycats; HIMS drops 20% - CNBC